{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:52:09Z","timestamp":1785606729888,"version":"3.56.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.yebeh.2009.01.018","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T04:19:57Z","timestamp":1233461997000},"page":"681-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: Does risk occur with therapeutic doses?"],"prefix":"10.1016","volume":"14","author":[{"given":"Federico","family":"Melani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Chiocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Muscas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2009.01.018_bib1","doi-asserted-by":"crossref","unstructured":"Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf 2003;2:233\u2013247.","DOI":"10.1517\/eods.2.3.233.21376"},{"key":"10.1016\/j.yebeh.2009.01.018_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1368-5031.2005.00731.x","article-title":"Antidepressants and seizures: emphasis on newer agents and clinical implications","volume":"59","author":"Montgomery","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.yebeh.2009.01.018_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/01.wnl.0000200993.33730.95","article-title":"Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures","volume":"66","author":"Maramattom","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2009.01.018_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","article-title":"Citalopram as treatment of depression in patients with epilepsy","volume":"27","author":"Specchio","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2009.01.018_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/ebeh.2000.0050","article-title":"The use of sertraline in patients with epilepsy: is it safe?","volume":"1","author":"Kanner","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2009.01.018_bib6","unstructured":"Cymbalta, European Public Assessment Report, Scientific Discussion."},{"key":"10.1016\/j.yebeh.2009.01.018_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perrucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.01.018_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0012162206000843","article-title":"Aggravation of epilepsy by anti-epileptic drugs","volume":"48","author":"Gayatri","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2009.01.018_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1528-1157.1998.tb01413.x","article-title":"Lamotrigine and seizure aggravation in severe myoclonic epilepsy","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.01.018_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.yebeh.2005.10.007","article-title":"Possible precipitation of myoclonic seizures with oxcarbazepine","volume":"8","author":"Kaddurah","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2009.01.018_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2009.01.018_bib12","first-page":"307","article-title":"The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity","volume":"89","author":"Welsh","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.yebeh.2009.01.018_bib13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archneur.62.6.946","article-title":"Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy","volume":"62","author":"Meschaks","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2009.01.018_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"Neurochemistry"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505009000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505009000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:21:48Z","timestamp":1761502908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505009000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1525505009000420"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2009.01.018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: Does risk occur with therapeutic doses?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2009.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}